4-bmc-experience is a common research chemical whereas the uses of the drug are multifarious in nature. It is a stimulant drug belonging to the cathinone class. The stimulant and anti-depressant nature of the drug has made it a lucrative drug for various medical treatments and therapies. It is available both in crystalline and powder form while the mode of ingestion is through the mouth. 4-bmc-experience is an addictive drug in nature and the long-term use of the drug can cause an addiction which is the reason why it is always recommended to take special care while using the drug. The side effects of the drug are also severe in nature in cases of overdose which is why its unauthorized use is highly discouraged. 4-bmc-experience is a controlled substance around the world.
What is the 4-bmc-experience?
is also known as. It is a stimulant drug belonging to the family of cathinone and amphetamine drugs.
has been designed to smooth out wrinkles whilst providing firmness and elasticity. If you want to maintain your youthful glow, It’s can help you achieve this by working in your skin to regenerate the dermis.
What’s in the box?
5 x 5ml or 10 x 5.0ml
drugs Originally synthesized by chemist Wayne E. Kenney, BAY is a drug which is a cannabinoid receptor agonist developed by Bayer AG. It has analgesic and neuroprotectiveeffects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury.
drugs has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury. It is a full agonist with around the same potency as CP 55,940 in animal studies, and has fairly high affinity for both CB1 and CB2 receptors, with Ki values of 2.91nM at CB1 and 4.24nM at CB2. It has been licensed to KeyNeurotek Pharmaceuticals for clinical development, and is currently in Phase II trials.But its development appears has stopped.
Originally synthesized by chemist Wayne E. Kenney, is a drug which is a cannabinoid receptor agonist developed by Bayer AG. It has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury.
Traumatic brain injury (TBI) is the most common cause of mortality and morbidity in adults under 40 years of age in industrialized countries. Worldwide the incidence is increasing, about 9.5 million people are hospitalized per year due to TBI, and the death rate is estimated to be more than one million people per year. Recently has been characterized as a structurally novel, selective and highly potent cannabinoid CB1/CB2 receptor agonist in vitro and in vivo with pronounced neuroprotective efficacy in a rat traumatic brain injury model, showing a therapeutic window of at least 5 h.
In conclusin you contact us via with email.